secwatch.observer — SEC 8-K summary
======================================

Issuer:     THC Therapeutics, Inc. (—)
CIK:        0001404935
Form:       8-K/A
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001477932-25-002821
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

THC Therapeutics board removes director Brandon Romanek; Romanek disputes removal as invalid
--------------------------------------------------------------------------------

- On April 2, 2025, majority shareholder voted to remove Brandon Romanek from board; remaining board removed him from all positions.
- Company requested Romanek's response; he provided a letter after the original 8-K was filed, now included as Exhibit 99.1.
- Romanek's letter states termination is invalid because proper procedure per THC Therapeutics bylaws was not followed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404935/000147793225002821/0001477932-25-002821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404935/000147793225002821/thct_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-002821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer